In vivo metabolism of N-phenyl-N′-(3,5-dimethylpyrazole-4-yl) thiourea in rats

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 4, 2003, Pages 273-278

  Kaymakçioǧlu, Bedia Koçyiǧit ^a   Rollas, Sevim ^a   Kartal Aricioǧlu, Feyza ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b Department of Pharmacology ^*  (Turkey)

Author keywords

In vivo metabolism; Rats; Thiourea

Indexed keywords

N PHENYL N' (3,5 DIMETHYLPYRAZOL 4 YL)THIOUREA; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG METABOLISM; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLITE; NONHUMAN; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 0346496483     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03220179     Document Type: Article

References (18)

1. Todoulou O.G., Papadaki-Valiraki A.E., Filippatos E.C., Ikeda S., De Clerq E. (1994): Synthesis and anti-myxovirus activity of some novel N,N′-disubstituted thioureas. Eur. J. Med. Chem., 29, 127-131.
2. Riccieri F.M., Porcelli G.A., Pastaris M.C. (1967): Thiourea derivatives and their antitubercular activity. Farmaco Ed. Sci., 22 (21), 114-120.
3. Doub B.Y.L., Richardson L.M., Herbest D.R., Block M.L., Stevenson O.L., Bambas L.L., Youmans G.P., Youmans A.S. (1958): Some phenylthiourea derivatives and their antituberculous activity. J. Am. Chem. Soc., 80, 2205-2217.
4. Vajragupta O., Pathamsakul A., Matayatsuk C., Ruangreangyngyad L., Wongkrajang Y., Foye W.O. (1996): Synthesis and antihypertensive activity of N-(alkyl/alkenyl/aryl)-N′-heterocyclic ureas and thioureas. J. Pharm. Sci., 85 (3), 258-261.
5. Küçükgüzel I., Rollas S., Çevikbaş A. (1995): Synthesis and characterizations of certin thiourea derivatives starting from 1,2,4-triazoline-3-thiones as potential antibacterial and antifungal agents. Drug Metab. and Drug Interact., 12(2), 151-160.
6. Bell F.W., Cantrell A.S., Högberg M., Jaskinas S.R., Johansson N.G., Jordan L.C., Kinnick M.D., Morin J.M., Noreen R., Öberg B., Palkowitz J.A., Parrish C.A., Pranc P., Sahlberg C., Ternansky R.J., Vasileff R.T., Vrong L., West S.J., Zhang H., Zhou X.X. (1995): Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors, 1.Synthesis and basic structure-activity relationship studies of PETT analogs. J. Med. Chem., 38, 4929-4936.
7. Cantrell S.A., Engelhardt P., Högberg M., Jaskinas R.S., Johansson G.N., Jordan L.C., Kangasmetsa J., Kinnick D.M., Lind P., Morin M.J., Muesing M.A., Noréen N., Öberg B., Pranc P., Sahlberg C., Ternansky R.J., Vasileff R.T., Vrong L., West S.J., Zhang H. (1996): Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Sythesis and further structure activity relationship studies of PETT analogs. J. Med. Chem., 39, 4261-4274.
8. Desai N.C., Bhatt J.J., Shah R.R., Undavia N.K., Triverdi P.B. (1996): Sythesis of substituted quinazolone derivatives as potential anti-HIV agents. IL Farmaco, 51(5), 361-366.
9. Dong Y., Venkatachalam T.K., Nafta R.K., Trieu V.N., Sudbeck E.A., Uçkun F.M. (2000): Antioxidant fuction of phenethyl-5-bromopyridyl thiourea compounds with potent anti-HIV activity. Bioorg. Med. Chem. Lett., 10, 87-90.
10. Uçkun F.M., Mao C., Pendergrass S., Maher D., Zhu D., Tuel-Ahlgren L., Venkatachalam T.K. (1999): N-[2-(1-cyclohexenyl)ethyl]-N′ -[2-(5-bromopyridyl)] thiourea and N′-[2-(1-cyclohexenyl)ethyl]-N′ -[2-(5-chloropyridyl)] thiourea as a potent inhibitors of multidrug-resistant HIV-1. Bioorg. Med. Chem. Lett., 9, 2721-2726.
11. Uçkun F.M., Pendergrass S., Maher D., Zhu D., Tuel-Ahlgren L., Mao C., Venkatachalam T.K. (1999): N′-[2-(2-thiophene)ethyl]-N′ -[2-(5-bromopyridyl)]thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant HIV-1. Bioorg. Med. Chem. Lett., 9, 3411-3416.
12. Jones A.R., Mashford P.M. (1983): The fat of N-methyl-N′ -(hydroxymethyl)thiourea in the rat. Xenobiotica, 13(2), 73-79.
13. Debruyne D., Moulin M.A., Bricard H., Bigot M.C. (1985): Liquid chromatographic determination of noxytiolin and 1-methyl-2-thiourea in serum: application to pharmacokinetic studies in rabbits and humans. J. Pharm. Sci., 74(2), 224-226.
14. Hucker H.B., Stauffer S.C., White S.D., Arison B.H., Zacchei A.G. (1982): Physiologic dispotion and metabolism of an anti-ulcer agent, N-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)-N, N′-dimethylurea, in rats, dogs and monkeys. Drug Metab. Dispos., 10(1), 28-34.
15. Kaymakçioǧlu B., Rollas S., Körceǧez E., Ariciǧlu-Kartal F. (2001): Evolution of anticonvulsant activity of N-substituted- N′-(3,5-dimethyl/1,3,5-trimethylpyrazole-4-yl)thiourea derivatives. 3rd International Symposium on Pharmaceutical Chemistry, September 17-19, Istanbul, P-24.
16. Kocyigit Kaymakcioglu B., Rollas S. (2002): Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones. IL Farmaco, 57, 595-599.
17. Oruç, E.E., Rollas S., Kabasakal L., Uysal M.K. (1999): The in vivo metabolism of 5-(4-nitrophenyl)4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats. Drug Metab. and Drug Interact., 15, 127-140.
18. Gülerman N.N., Oruç E.E., Kartal F., Rollas S. (2000): In vivo metabolism of of 4-fluorobenzoic acid[(5-nitro-2-furanyl)methylene]hydrazide in rats. Eur. J. Drug Metab. Pharmacokinet., 25(2), 103-108.